Quick answers
- What is Mecamylamine hydrochloride used for?
- The FDA-approved label (Vecamyl, TILDE Sciences LLC, February 20, 2025) says: “For the management of moderately severe to severe essential hypertension and in uncomplicated cases of malignant hypertension.” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Mecamylamine hydrochloride have a boxed warning?
- No. None of the 2 FDA labels we found for this medicine has a boxed warning.
- Is there a shortage of Mecamylamine hydrochloride?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Mecamylamine hydrochloride been recalled?
- No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
- Who makes Mecamylamine hydrochloride?
- 2 companies list prescription products of Mecamylamine hydrochloride in the FDA NDC Directory, including Vyera Pharmaceuticals, LLC and TILDE Sciences LLC.
What Mecamylamine hydrochloride is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
For the management of moderately severe to severe essential hypertension and in uncomplicated cases of malignant hypertension.
— FDA label: Vecamyl, TILDE Sciences LLC, effective February 20, 2025. Read the full label on DailyMed →
The FDA has 2 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Conditions named on the label
These condition names appear word for word in the label’s “Indications and Usage” text (matched with a reviewed table). Each page lists hospitals whose own websites name the condition.
Related medical specialties
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
0 of 2 FDA labels for this medicine have a boxed warning.
Forms and how it is given
| Dosage forms | Tablet |
|---|---|
| Route | Oral |
| Prescription products | 2 in the FDA NDC Directory |
| Brand names | Vecamyl |
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Vyera Pharmaceuticals, LLC1 product
- TILDE Sciences LLC1 product
FDA approval history
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
Generic approvals (1)
- ANDA204054Lgm Pharma · March 19, 2013
Shortage status
The FDA drug shortage list does not show these products.
Recalls
No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.
Official identifiers
| RxCUI (RxNorm) | 1298874, 1373008 |
|---|---|
| SPL set ID of the quoted label | 0b149023-f7a8-442d-ac69-295df8e66ed3 |
| FDA labels (SPL) | 2 |
| FDA applications | 1 ANDA |
| Active ingredients (FDA) | MECAMYLAMINE |
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Vecamyl, TILDE Sciences LLC, effective February 20, 2025; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →